Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

• By Michael Cipriano

Related Content

FDA Labeling Change Rule Is Most Prominent Item On Agency’s To-Do List

Jul 22 2013

CDER Director Woodcock Plans Changes To Drug Reviews During OND Transition

Mar 07 2017

'Repeal And Replace' Going Relatively Well For Pharma So Far

Mar 13 2017

Bill To Speed ANDA Approvals Gets Cool Reception From Industry, US FDA

Mar 03 2017

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Jan 31 2017

Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking

Jan 12 2017

Von Eschenbach’s Commissioner Debut May Be Release Of Safety Report

Dec 11 2006

‘Intended Use’ Rule: Industry Urges US FDA To Revoke ‘Totality Of Evidence’ Standard

Feb 13 2017

US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says

Feb 14 2017

The Evolution Of 21<sup>st</sup> Century Cures Legislation

Nov 30 2016

Review Voucher Program For Rare Pediatric Diseases Should Not Be Reauthorized, US FDA Says

Mar 03 2016

Off-Label Wish List: Industry Groups Want US FDA's Guidances To Do More

Mar 09 2017

Trump Slams FDA Regulations In Joint Session Of Congress

Mar 01 2017

Related Companies

Sanofi

GSK plc

Additional Topics

United States Leadership Regulation FDA BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window